Typology: how a Parisian DTC brand disrupted La Roche-Posay’s pharmacy monopoly with numbered serums and radical transparency

The BlaBlaCar connection

Typology's founder isn't a cosmetic chemist or a third-generation perfumer from Grasse. Ning Li is a tech entrepreneur who co-founded BlaBlaCar, Europe's largest carpooling platform. He came to skincare the way tech founders come to every industry: by looking at the existing market, identifying the information asymmetry that protected incumbent margins, and building a product that eliminated it.

The information asymmetry in French skincare was this: consumers trusted French pharmacy brands implicitly — La Roche-Posay, Bioderma, Avene, Vichy — but couldn't actually compare formulations because ingredient lists were buried in fine print, concentrations were trade secrets, and the pharmacy channel created a pricing floor that kept even basic serums above thirty euros. French women knew they were buying quality. They didn't know whether they were buying thirty euros of quality or eight euros of quality in thirty euros of packaging.

Li's thesis was that a DTC brand could eliminate the pharmacy middleman, publish complete formulations, strip packaging to the minimum, and sell serums at ten to twenty-five euros — and that the transparency itself would become the brand's marketing. He wasn't wrong.

The numbered system

Typology's product naming convention is its most recognisable design decision. Every product carries a number that corresponds to its primary active ingredient and concentration. Niacinamide 12% Serum tells you exactly what's in it and at what percentage. Hyaluronic 3% Serum does the same. There's no clever product name to decode, no aspirational branding to parse, no "Midnight Recovery" or "Advanced Génifique" that requires a marketing glossary to understand.

This naming convention does three things simultaneously. First, it empowers comparison shopping — if you know you want a niacinamide serum at 10%+, you can compare Typology's offering against The Ordinary, Paula's Choice, and any other brand that publishes concentrations. Second, it signals transparency as a brand value — the willingness to put the number on the label implies there's nothing to hide. Third, it attracts the informed consumer — the person who reads INCI lists, follows dermatologists on Instagram, and treats skincare like an evidence-based practice rather than a vibes-based one.

The system also creates a natural discovery path. A consumer who buys the niacinamide serum and likes it can scan the numbered range and find their next product by ingredient rather than by marketing claim. "I liked niacinamide, I want to add vitamin C" becomes "I'll try the Vitamin C 15% serum." The catalogue becomes browseable in the way a wine list is browseable — by varietal rather than by label.

The Ordinary comparison (and the difference)

Every review of Typology mentions The Ordinary, and the comparison is fair. Both brands sell single-active serums at budget prices. Both publish concentrations. Both strip packaging to clinical minimalism. But the differences are meaningful.

The Ordinary is Canadian-born, DECIEM-owned, positioned as the "clinical formats nobody told you about." Its aesthetic is laboratory — clinical serums in dropper bottles, packaging that looks like it belongs in a research facility. Typology is Parisian, independently owned, and positioned as the "French pharmacy reimagined." Its aesthetic is design-forward — amber glass, minimalist typography, packaging that looks like it belongs in a concept store in Le Marais.

The formulation philosophy differs too. The Ordinary tends toward pure single-actives — one ingredient, minimal supporting cast, maximum concentration. Typology builds what it calls "targeted serums" — a primary active (published at concentration) supported by complementary botanicals that the brand sources from organic supply chains. Typology Retinol 0.3% Serum doesn't just contain retinol — it contains retinol buffered with bakuchiol and squalane to reduce irritation. Typology Bakuchiol 1% + Vitamin E Night Serum pairs the retinol alternative with vitamin E for antioxidant support.

The result is a range that's more accessible to the consumer who's intimidated by pure actives. Typology's serums are less likely to irritate, less likely to require complex buffering routines, and more likely to work as standalone products rather than as building blocks in a ten-step protocol.

The skin diagnostic

Typology's website features an online skin diagnostic — a questionnaire that assesses skin type, concerns, lifestyle factors, and environmental exposure, then recommends a personalised routine from the numbered range. The diagnostic is the tech founder's fingerprint: data-driven recommendation, algorithmic matching, personalisation at scale.

The diagnostic serves a business purpose beyond customer service. It captures preference data that informs product development. If thousands of diagnostic results show a cluster of consumers with combination skin, hyperpigmentation, and sensitivity — and Typology doesn't have a product that addresses all three — that's a product development brief generated by demand data rather than trend forecasting.

It also solves the paradox of the numbered range. A catalogue of thirty-plus numbered serums is transparent but overwhelming. The diagnostic acts as a concierge, filtering the range down to four or five products that match the individual consumer. It's the pharmacy experience — pharmacist assesses skin, recommends products — rebuilt as software.

The pricing disruption

Typology's pricing is its most aggressive competitive weapon. The Radiance Serum 15% Vitamin C sells for roughly fifteen euros. A comparable stabilised vitamin C serum from La Roche-Posay costs forty-plus euros. From SkinCeuticals (the gold standard), it costs over a hundred.

The price gap is partially explained by the DTC model — no pharmacy margin, no department store margin, no distributor margin. But it's also a deliberate positioning choice. Li has been open about the fact that Typology's margins are lower than industry standard because the brand's growth strategy relies on volume and repeat purchase rather than premium pricing. The bet is that a consumer who buys a fifteen-euro serum, likes it, and adds three more products from the range is more valuable than a consumer who buys one forty-euro serum and churns.

This pricing strategy has a secondary effect: it pressures the pharmacy channel. When a consumer can buy a niacinamide serum from Typology at twelve euros and a nearly identical product from Bioderma at thirty-five euros, the pharmacy brand needs to justify the premium with something beyond formulation — clinical studies, dermatologist endorsement, brand heritage. Typology doesn't attack these justifications directly. It just sits at a price point that makes consumers ask whether they're paying for the product or for the pharmacy's rent.

The clean-beauty credential

Typology arrived during the clean-beauty wave but positioned itself differently from most clean brands. Instead of leading with what's excluded (no parabens, no sulphates, no silicones), Typology leads with what's included — active ingredients at published concentrations, sourced from organic supply chains where possible, formulated with a minimum of inactive ingredients.

The brand publishes a "naturalness score" for each product — the percentage of ingredients that are of natural origin. It also publishes the complete INCI list with explanations of what each ingredient does. This level of disclosure goes beyond what French regulations require and significantly beyond what most pharmacy brands offer.

The approach avoids the clean-beauty trap of defining quality by absence. Typology doesn't claim that parabens are dangerous (the scientific consensus says they're safe at regulated concentrations). It claims that it can formulate effective products without them — a subtler position that doesn't require demonising ingredients to sell alternatives.

What the range looks like now

The core range spans roughly forty products, all following the numbered convention. The serums are the heroes:

Niacinamide 12% Serum targets pore refinement and oil control — the product for combination and oily skin types who want visible pore reduction without drying.

Hyaluronic 3% Serum delivers multi-weight hyaluronic acid for deep and surface hydration — the hydration serum for the person who wants plumpness without heaviness.

Retinol 0.3% Serum is the evening treatment — retinol buffered with bakuchiol for the consumer who wants anti-aging efficacy without the irritation roulette of higher-concentration retinoids.

Bakuchiol 1% + Vitamin E Night Serum is the retinol alternative — for the consumer who can't tolerate retinol, is pregnant, or simply prefers plant-derived actives.

Radiance Serum 15% Vitamin C is the brightening play — stabilised vitamin C at a concentration that rivals prestige brands, at a fraction of the price.

The disruption thesis, tested

Three years after launch, Typology is the fastest-growing French skincare brand by revenue growth rate. It hasn't replaced La Roche-Posay — the pharmacy channel is too entrenched for that. But it has created a parallel channel: the informed, digitally native consumer who trusts data over pharmacist authority, who reads ingredient lists before marketing copy, and who sees no reason to pay pharmacy premiums for formulations she can evaluate herself.

Typology proved that the French skincare market — long considered impenetrable by outsiders — had the same vulnerability as every other legacy market: a generation of consumers who preferred transparency to tradition, numbers to narratives, and fifteen euros to forty. Ning Li didn't disrupt French pharmacy with a better formula. He disrupted it with a better spreadsheet.